Clearside Biomedical Inc. (NASDAQ: CLSD)
$1.22
-0.0250 ( -2.02% ) 185.5K
Clearside Biomedical Inc is a United States-based clinical biopharmaceutical company. It is engaged in developing pharmacological therapies to treat blinding disease of the eye through the suprachoroidal space, or SCS. The company's novel SCS injection platform, utilizing proprietary SCS Microinjector, enables an in-office, repeatable, non-surgical procedure for the targeted and compartmentalized delivery of a wide variety of therapies to the macula, retina or choroid to potentially preserve and improve vision in patients with sight-threatening eye diseases.
Market Data
Open
$1.22
Previous close
$1.24
Volume
185.5K
Market cap
$91.17M
Day range
$1.19 - $1.25
52 week range
$0.65 - $2.12
SEC Fillings
Form Type | Description | Pages | Date |
---|---|---|---|
4 | Insider transactions | 1 | Mar 20, 2024 |
4 | Insider transactions | 1 | Mar 18, 2024 |
3 | Insider transactions | 2 | Mar 18, 2024 |
8-k | 8K-related | 14 | Mar 12, 2024 |
10-k | Annual reports | 81 | Mar 12, 2024 |
4 | Insider transactions | 1 | Feb 09, 2024 |
8-k | 8K-related | 21 | Feb 08, 2024 |
8-k | 8K-related | 12 | Feb 01, 2024 |
4 | Insider transactions | 1 | Jan 19, 2024 |
4 | Insider transactions | 1 | Jan 19, 2024 |